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Abstract
Background: Vector control programs, which have focused mainly on the patient house and peridomestic areas
around dengue cases, have not produced the expected impact on transmission. This project will evaluate the
assumption that the endemic/epidemic transmission of dengue begins around peridomestic vicinities of the
primary cases. Its objective is to assess the relationship between symptomatic dengue case exposure and
peridomestic infection incidence.
Methods/Design: A prospective cohort study will be conducted (in Tepalcingo and Axochiapan, in the state of
Morelos, Mexico), using the state surveillance system for the detection of incident cases. Paired blood specimens
will be collected from both the individuals who live with the incident cases and a sample of subjects residing
within a 25-meter radius of such cases (exposed cohort), in order to measure dengue-specific antibodies. Other
subjects will be selected from areas which have not presented any incident cases within 200 meters, during the
two months preceding the sampling (non-exposed cohort). Symptomatic/asymptomatic incident infection will be
considered as the dependent variable, exposure to confirmed dengue cases, as the principal variable, and the
socio-demographic, environmental and socio-cultural conditions of the subjects, as additional explanatory variables.
Discussion: Results indicating a high infection rate among the exposed subjects would justify the application of
peridomestic control measures and call for an evaluation of alternate causes for insufficient program impact. On
the other hand, a low incidence of peridomestic-infected subjects would support the hypothesis that infection
occurs outside the domicile, and would thus explain why the vector control measures applied in the past have
exerted such a limited impact on cases incidence rates. The results of the present study may therefore serve to
reassess site selection for interventions of this type.
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Background
Dengue, the most frequent vector-borne viral disease in
the world, constitutes a public health problem in tropi-
cal and subtropical countries [1]. In its 2008 and 2009
reports to the World Health Organization, Mexico
reported 31,154 and 55,363 confirmed dengue cases
(24.42 cases per 100,000 inhabitants), with 24 and 96
fatality cases, respectively.
Dengue affects the productivity of countries signifi-
cantly, and generates losses that are as important as
those caused by tuberculosis, Chagas, leishmaniasis,
hepatitis and malaria, among others [2-5]. For instance,
the total cost of the Cuban epidemic in 1997 ascended
to 10,251,539 USD, taking into account the money
invested in vector control and patient care [6]. More-
over, the direct economic impact of the disease is com-
pounded by the disability-adjusted life years (DALYs)
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[2,4]. For example, in Puerto Rico, from 1984 to 1994,
dengue caused an average of 658 DALYs per million
inhabitants per year, with a maximum of 2,153 DALYs
per million inhabitants estimated for 1994. The greatest
burden of disease was attributed to dengue fever [4].
It has been established that Dengue virus (DENV)
transmission involves a man-vector-virus pathway, but
the characteristics and dynamics of the related factors
have not been fully determined [7]. Firstly Aedes aegypti
and secondly Aedes albopictus mosquitoes have been
found to be the leading dengue vectors in the world.
However, the virus has also been isolated from species
such as Ae. albifasciatus and Ae. polinensis [8].
The dengue endemic/epidemic cycle is maintained by
the vector through mosquito-man- mosquito transmis-
sion. On contracting the virus, mosquitoes remain
infected and asymptomatic for the remainder of their
lives. Human beings are both the definitive host and the
reservoir of the virus. A female mosquito feeds on a
number of humans during the day. Once it has bitten
an infected individual, it incubates the virus for a period
of 7-14 days, and then starts to infect healthy individuals
through its bite. In humans, DENV incubation extends
over a period of 3 to 14 (7 on average) days. The actual
infectious stage, or time span during which the diseased
person spreads the infection to a vector, commences
one to two days before the onset of symptoms, at which
time high levels of viremia appear and continue to
develop throughout a febrile cycle of 2 to 10 days [9].
The DENV infection spectrum covers symptomatic
cases (dengue fever, dengue hemorrhagic fever, dengue
shock syndrome and death), as well as asymptomatic
cases, which, in most studies, represent over half of total
infections [10-23]. It has been proposed that the high
frequency of asymptomatic cases may be contributing to
the maintenance of human transmission despite the
reduced number of vectors during inter-epidemic peri-
ods [24]. Likewise, as the level of viremia required to
produce clinical manifestations is currently unknown
[25] and asymptomatic viremic cases of dengue have
been reported [14,26], the asymptomatic cases may con-
stitute a determinant of persistent dengue transmission.
Being at least as frequent as the symptomatic cases, and
not having been combated by preventive measures of
any sort, these may well be a source of vector infection,
and could thus be generating a significant impact on the
spread of dengue among different populations.
Given the absence of a DENV-specific vaccine or anti-
viral treatment, health services have focused their pre-
vention efforts on vector control. Government vector
control programs offer a number of partially successful
examples. For instance, in 1965, a PAHO campaign
against urban yellow fever (consisting of DDT and
malathion spraying) eradicated Ae. aegypti from
America and, collaterally, attenuated dengue. However,
the program was discontinued in the early 1970s and
America has been reinfested with Aedes. A second par-
tially successful example occurred in Singapore in 1973,
when a government program based on entomological
surveillance, larval breeding-site reduction, education
and the enforcement of legislation to control Ae. aegypti
and Ae. albopictus, slashed the House Index (HI) from
50% to 2% and curbed dengue prevalence. Notwith-
standing, at 15 years, dengue incidence has intensified,
without, however, hoisting the HI [27].
Cuba provides yet another example of success: subse-
quent to its 1981 epidemic, the Cuban government con-
ducted a vector eradication campaign where both vector
and dengue were eliminated from the island for 15
years. After 1997, however, despite a stable 1% HI, the
virus resurged in certain localities, probably due to a
drop in herd immunity and transmission by interna-
tional travelers. In the two aforementioned cases, gov-
ernment programs have achieved long-term dengue
control as a result of the countries’ political will and
geographic conditions.
At the government level, vector control measures have
concentrated on peridomestic dengue areas. For
instance, the Mexican National Health Standard obli-
gates the state health services to execute larval control
and dejunking campaigns permanently, as well as nebu-
lization and fumigation procedures during peak trans-
mission periods, targeting the domiciles and
peridomestic vicinities of dengue cases detected through
epidemiological surveillance. Nevertheless, the results
have fallen short of expectations.
In this regard, a literature review of Esu E, et al [28]
was conducted to evaluate the effectiveness of perido-
mestic space fumigation for reducing dengue transmis-
sion and yielded no conclusive evidence of reduction
through this measure: only one of the 15 studies
reviewed reported an impact on the disease (a reduction
of case incidence during the four weeks subsequent to
the intervention). In this instance, however, the applica-
tion of insecticides was coupled with anti-breeding cam-
paigns. While 13 studies reported initial cuts in the
entomological indices, most cases achieved only an
ephemeral impact. As a result, the authors of the review
sustain that a reduction in entomological indices does
not necessarily imply a reduction in transmission, due
to the presence of additional factors relating, for
instance, to herd immunity, population density, circulat-
ing serotype and a number of other environmental vari-
ables [28]. Further potential factors include a rise in
extra-domiciliar transmission, changes in vector surveil-
lance policies and migratory movements [27].
Moreover, as regards vector density and its relation to
dengue, a study in Thailand reported a negative
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correlation between the Breteau Index and dengue inci-
dence [24]. Another study in Brazil revealed not only
that the peak case incidence period was not preceded by
a rise in vectors in the locality, but also that mosquito
density was low when the occurrence of cases was the
highest, thus suggesting that infection took place outside
the case domiciles (schools, workplaces, etc.) [29]. Other
transmission-related factors have been contemplated,
such as: age, low educational and income levels, the
number of occupants per room, houses -not apart-
ments- as dwellings, study and work sites outside the
home, and subject movement patterns [23,24,30-32].
Regarding intra and peridomestic transmission, a
study in Thailand reported that only 13 out of 180
families with subjects hospitalized for dengue presented
more than one hospitalized case in their households
[33]. Another study in Puerto Rico evaluating the occur-
rence of infection with a four-month follow up found
that out of the 189 sample households (with two or
more persons residing with an incident case) 95 pre-
sented at least one infected individual during follow up,
and only 50 of these indicated two or more infected
individuals [23].
So far, three studies reported in the literature have
evaluated infection in the vicinity of pediatric index
cases (through cluster sampling). The first, conducted in
Indonesia with a 14 day follow up, included persons liv-
ing with and neighbors residing within a 10-meter
radius of the cases. The results indicated a recent-infec-
tion rate of 24.5% (192/785 cases, 17 of which consisted
of post-enrollment infections). The index case serotype
was analyzed and compared to that of the infected indi-
viduals in the surrounding areas: it proved identical in
four out of the seven clusters studied, but different in
three [26]. The second study, conducted in Thailand
with a 15-day follow up, sampled children aged six to
15 years residing within a 100-meter radius of the index
cases’ dwellings. Twelve positive clusters (with an index
case) and 22 negative clusters (with no index case) were
analyzed, yielding an incidence rate of 12.4% in the first
and 0% in the second (with an attributable risk of 10.4%
and a CI of 95% 1-19.8%) [13].
Thirdly, a recent study conducted in Nicaragua with a
14-day follow up reported infection in 2.4% (10/414) of
the subjects in the 18 positive clusters (composed of
individuals aged two and older residing with or within a
50-meter radius of the confirmed dengue index cases)
and 2.5% (2/81) of the subjects in the four negative clus-
ters (composed of persons residing with and neighbors
of dengue-negative febrile cases) studied. Additionally,
the viral sequences of three index cases and four con-
tacts were analyzed, with the sequence of only one con-
tact diverging from that of its index case [10].
In sum, the relationship among the dengue transmis-
sion pattern, the incidence of the disease and the density
of Ae. aegypti is still unclear. Vector-control programs
targeting the peridomestic vicinities of cases have not
achieved the desired results, and the causes are
unknown. They may include inadequate insecticide
application, vector resistance to the insecticides applied,
non-continuity of the measures implemented and the
fact that transmission is not occurring -or is occurring
less than expected- within the peridomestic areas.
Hence, identifying the relationship between exposure
to a dengue case in its peridomestic vicinities and the
frequency of new infections would help to shed light on
the dengue-transmission pattern in endemic urban
areas. Additionally, the results of this study would both
contribute to improve control activities with the purpose
of achieving a greater impact on the burden imposed by
dengue, and help to give the resources destined for vec-
tor control a more efficient use. This is particularly criti-
cal in the dengue-endemic areas where budgets for
interventions of this type are restricted.
Methods/Design
Objectives
The general objective of the present study is to assess
the relationship existing between a clinical case of den-
gue identified under the epidemiological surveillance
system and the DENV infection incidence among the
subjects residing in the domicile and peridomestic areas
of such case.
In order to achieve this, the frequency of DENV infec-
tion will be determined in subjects both exposed and not
exposed to confirmed dengue cases in their vicinities
(index cases). The relationship between the incidence of
infection and several socio-demographic, sociocultural
and environmental variables will be evaluated. A multi-
variate model susceptible of explaining the incidence of
DENV infection in the area will be constructed. And the
extent to which the estimated vector density explains the
relationship between the incidence of infection and peri-
domestic exposure to a dengue case will be assessed.
Design and population
A prospective cohort study will be conducted in a den-
gue-endemic urban area with subjects aged five and
above who reside in the Tepalcingo and Axochiapan
localities and authorize their inclusion in the study.
Individuals, for whom follow up is impossible, will be
excluded.
Study area
The towns of Tepalcingo and Axochiapan (seat of the
municipal government) are localities
Martínez-Vega et al. BMC Public Health 2012, 12:262
http://www.biomedcentral.com/1471-2458/12/262
Page 3 of 11
belonging to the third sanitary jurisdiction of state of
Morelos. Tepalcingo (N18° 35’ 47”, W98° 50’ 37”) rises to
1,160 meters above sea level, covers an area of 4,062,478
m2, and has a population of 12,053; Axochiapan (N18°
30’ 9”, W98° 45’ 14”) rises to 1,030 meters above sea
level, covers an area of 8,967,290 m2, and has a popula-
tion of 16,255, according to the 2010 census [34].
Variables
Dependent variable: recent (symptomatic or asympto-
matic) DENV infection confirmed through paired
serology.
Main independent variable: exposure to an “index
case–IC,” that is, a dengue case identified through the
jurisdictional epidemiological surveillance system, and
confirmed through the algorithm applied by the Health
Services of Morelos (abbreviated to SSM in Spanish).
Under the SSM algorithm, serum is tested with NS1
ELISA during the first five days of febricity. If the results
are negative, IgM ELISA is applied, and if those are
negative as well, a quantitative IgG test is performed.
Additionally, culturing or RT-PCR analyses are per-
formed on 10% of the confirmed cases to obtain the cir-
culating serotypes. Where the blood samples are drawn
on day six of febricity or thereafter: first, an IgM mea-
surement is performed, and, if the results are negative, a
quantitative IgG test is applied as well.
Potential confounding variables: age, gender, mobi-
lity (over the past 15 days, evaluated by means of a
questionnaire), human population density and vector-
reduction interventions executed by the participating
subjects and/or SSM.
Other independent variables: educational level, occu-
pation, household characteristics, estimated Ae. aegypti
abundance and their infection with DENV. The circulat-
ing viral serotype will be monitored in an IC subsample,
although changes are not expected to occur due to lim-
ited sampling space and time. Although climatic vari-
ables are likely to be identical in the exposed and non-
exposed groups, temperature, rainfall and humidity will
be monitored on the basis of data provided by either
SSM or the State Commission for Water and the Envir-
onment (abbreviated to CEAMA in Spanish).
Sample size
According to epidemiological data collected recently
(2006-2010) in Tepalcingo and Axochiapan, local DENV
incidence averages 44.1 and 46.5 notified confirmed
cases/10,000 inhabitants respectively, and afflicts all age
groups (Figure 1) (data provided by SSM). However,
given the presence of significant endemic-area incidence
variation, the sample calculation for the study is based
on an incidence of 20 notified cases per 10,000 inhabi-
tants per year.
Given that febrile dengue cases are underreported in
endemic areas (4 non-reported cases per reported case)
[35], the febrile case incidence in Tepalcingo and Axo-
chiapan is expected to reach only 100/10,000 inhabi-
tants. Further, bearing in mind that at least 50% of
infections are asymptomatic [10-23], the infection rate
in the Tepalcingo and Axochiapan endemic areas is
expected to average a minimum of 2% annually. With
80% of infections estimated to occur during the study
evaluation and follow-up months (Figure 2), the DENV-
infection incidence in the non-exposed group is
expected to represent 1.6%.
Figure 1 Dengue incidence per 10,000 inhabitants per year,
according to age, Tepalcingo and Axochiapan, Morelos,
México.
Figure 2 Monthly distribution of confirmed dengue cases in
Tepalcingo and Axochiapan.
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Considering a statistical power of 80%, a confidence
level of 95%, an incidence of 1.6% in the non-exposed
group, a 1:1 exposed:non-exposed group relation, an
estimated Relative Risk (RR) of 3 and a loss of 10% dur-
ing follow up, a total of 1,178 subjects will need to be
evaluated. Calculations were performed with the Stata
9.2 SE software.
Sampling, training and follow up
The Morelos state dengue surveillance system will be
used to detect the ICs, and these will be visited at home
for a standardized interview including questions on
socio-demographic and mobility variables.
Exposed group
All individuals aged five and above residing in the ICs’
domiciles will be invited to participate in the study.
Those who accept will be applied a standardized inter-
view with variables regarding their socio-demographic
and mobility status, their household characteristics, and
the presence of symptoms over the past 15 days (every
household will be GPS referenced). Additionally, initial
10-ml blood samples (baseline samples) will be collected
from the subjects, and entomological surveys will be
conducted in their homes, during which mosquito larvae
and pupae will be actively sought within all the contain-
ers in the properties, according to the Focks and Pan
American Health Organization methodology recommen-
dations [36,37]. Each container will be classified under
the EA1 entomology format of the Mexican Ministry of
Health. A two-person team will gather samples. Each
team will collect all the larvae/pupae present in the
small containers (of less than 5 liters). The larvae/pupae
samples in the larger containers will be collected by net
sweeping each container three times. Subsequently, all
larvae/pupae will be dispatched alive to the National
Institute of Public Health (INSP) insectary for classifica-
tion and DENV-infection evaluation of the emerging
mosquitoes.
Three months (± 7 days) after the initial evaluation, a
follow-up visit will be made to the domicile of each IC
to: inquire about the onset of any symptoms during the
preceding week, take a second blood sample of 6 ml
(follow-up sample) and conduct another household
entomological survey.
Between the baseline and the follow-up evaluation,
active monitoring will be carried out by means of a
weekly telephone call, to ascertain whether any febrile
events have taken place among the participants. During
two days, five phone call attempts will be made at one-
hour intervals, but if telephone contact proves impossi-
ble, the subjects will be visited at home. Passive moni-
toring will also be carried out by consulting the SSM
records to check whether any participants have been
reported as suspected dengue cases by the local health-
care centers.
In a 50 meters area next to IC house (that is, inside a
circular area with a 25-meter radius) four houses will be
invited to participate (Figure 3). The subjects who
accept to participate in the study will be applied the
same questionnaire, blood sampling and infested-con-
tainer inspection procedures as those previously applied
to the persons residing with the ICs,
It is expected that a total of 15-20 exposed subjects
will be enrolled per IC. Of these, three are anticipated
to be intradomiciliar, and the rest, 12-17 individuals,
peridomestic residents. According to least information
available (2005 census), in the study area there are five
occupants on average per household. In terms of our
study, one of these will be the IC, and another will
Figure 3 Sampling of exposed and non-exposed subjects.
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either not accept to participate or be under five years
and therefore ineligible for the study.
Non-exposed group
The same week the exposed group is enrolled, sampling
will be carried out in those areas that both have not
presented ICs in the past two months and are situated
within 200 meters of the ICs (the vector flight range
reaches a maximum radius of 100 meters) [13]. In a 50
meters circle centered on the first house that at least
one person agree to participate other four houses will
be to invite to participate as we described for the
exposed group (Figure 3). Those who accept will be
evaluated in the same manner as the exposed-group
subjects. It is expected that 15-20 non-exposed indivi-
duals will be included per group of 15-20 exposed indi-
viduals. To achieve the calculated sample size,
approximately 40 ICs will be evaluated such that 589
exposed and 589 non-exposed subjects may be included
in the study.
Furthermore, to avoid oversampling geographic areas,
a simulation study was conducted as a means of deter-
mining the approximate minimum size required for the
study area to ensure with high probability, 40 exposure
and 40 non-exposure sections with a diameter of 50
meters each (that is, without overlapping surfaces).
Under the simulation study, it was considered that
infected individuals turn up randomly throughout the
area and that, as a result, the determination of their
control sites is also entirely random. This simulation
scenario is conservative, as it represents the least favor-
able situation for producing non-overlapping circles; the
true pattern of infection almost surely gives rise a more
suitable sampling scheme. According to the simulation
procedure, Tepalcingo and Axochiapan offers an ade-
quate study area, as it allowed for obtaining 40 infected
subjects and their corresponding 40 cohorts in 100% of
the exercises.
Dengue diagnosis in the subjects (outcome)
Diagnoses will be confirmed by means of paired DENV-
specific IgM and IgG ELISA (baseline and follow-up
samples) (Panbio Cat No. E-DEN02G and E-DEN01M).
Initial IgM detection will be performed on paired sam-
ples from each subject, and will be followed by paired
IgG tests if results are inconclusive.
Colorimetric readings will be performed with a micro-
plate reader in accordance with the supplier instructions
on the diagnosis box. Interpretations will be made with
a cutoff value of 0.200 (pre-established with samples
from both healthy and diseased individuals in the area),
Values equal to or higher than cutoff will be considered
as positive; those under cutoff will be considered as
negative.
Events covering any of the following conditions will be
considered as confirmed recent DENV infections: (1)
seroconversion (presence of negative antibodies in the
baseline and positive antibodies in the follow-up sam-
ple); (2) quadriplication of antibody titles between the
baseline and the follow-up sample, and (3) availability of
a viral isolation result indicating a positive RT-PCR or
NSI during the three follow-up months because the sub-
ject has developed a febrile manifestation and has
attended SSM for consultation [38].
Subjects will be considered to be without recent
DENV infection if the results from their DENV-specific
IgM and/or IgG tests are negative, or the matched study
samples do not indicate a rise in antibodies.
Estimated abundance of mosquitoes
One direct and one indirect estimation will be imple-
mented. The latter will apply data from the entomologi-
cal surveillance system based on the use of SSM
ovitraps, which consists in one-year weekly revisions of
100 ovitraps distributed throughout 25 neighborhood
blocks within the locality (one ovitrap for each side of
the block) (Figure 4). The relative abundance of vectors
in the participating dwellings will be estimated with the
information obtained from all ovitraps, based on a sur-
face that interpolates the abundance values of the sam-
ple sites correlating with suitable covariates at hand
over the whole study area, such as solar radiation, con-
struction and vegetation densities, altitude, etc. The
determination of the specific interpolation method will
depend on both the type of data obtained during sam-
pling and the type and relevance of covariates available
over the study area.
The information gathered during the baseline and fol-
low-up surveys of all the participating households will
serve directly to calculate the positive-container index
(number of infested containers/number of water con-
tainers inspected) and the Breteau index (number of
positive containers /number of households inspected)
for each IC-exposed and non-exposed group.
Monitoring Ae. aegypti DENV infection
Not only the mosquitoes that emerge from the larvae/
pupae collected at the dwellings of the participating sub-
jects will be analyzed, but also those that emerge from
the eggs ovitrapped within a 200-meter radius of the
dwellings and collected during the specific IC-enroll-
ment week, the two previous weeks and the subsequent
week.
Viral isolation will be performed by culturing mos-
quito C6/36 (Ae. albopictus) cells. Groups of 5-10 mos-
quitoes will be formed and macerated. The macerate
will then be centrifuged, the supernatant will be filtered,
and 50 μl of the resulting fluid will be drawn to inocu-
late the C6/36 cells. These will be incubated at 28°C for
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approximately 8 days. Then, the cultures will be centri-
fuged, the cell package will be suspended in PBS, and
the suspension will be deposited in five fluorescence
slides to be air-dried for one hour and then fixed with
-20°C absolute acetone. Next, the preparations will be
rehydrated in PBS. First, screening dye (direct immuno-
fluorescence) will be applied. For this purpose, one of
the five slides will be incubated with an anti-flavivirus
antibody conjugated to fluorescence (direct conjugation,
pool of human DENV-positive ELISA-tested sera).
Figure 4 Location of ovitraps in Tepalcingo(A) and Axochiapan (B), 2011.
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Afterwards, it will be washed in PBS and mounted in
glycerol-PBS for reading.
In the positive samples, the serotype will be identified
by incubating the remaining slides with specific mono-
clonal serum antibodies and developing the interaction
with an anti-IgG antibody from a mouse conjugated to
Alexa 488. Next, the preparations will be washed in PBS
and incubated with the diluted G-Alexa anti-mlg anti-
body. Lastly, the preparations will be washed once more
in PBS and mounted in glycerol-PBS for reading.
Geographic Information System (GIS)
Geographic data on the study area, neighborhoods,
blocks, schools, ovitraps, roads, satellite images and con-
tour lines will be compiled and consolidated. The den-
gue cases reported to the Sole Dengue Epidemiological
Surveillance Platform (Plataforma Única de Vigilancia
Epidemiológica de Dengue) during the study period will
be geo-referenced with GPS (Global Positioning System)
devices. ArcGIS10 software will be used to develop the
GIS application. The aforementioned data will be conso-
lidated under the GIS, and 200- and 50-meter buffers
will be traced to determine which households will be
contemplated under the follow-up survey. Both the
demographic and survey data -including the Breteau
Index- will be matched to the study blocks.
Data collection and storage
To collect data, an online entry and follow-up system
will be developed and pilot tested. The system will
include formats for: the screening exercise, the subject
baseline survey, the household baseline evaluation, the
telephone-follow-up activity, the subject follow-up sur-
vey and the household follow-up evaluation. Formats
will encompass socio-demographic, mobility and health
status variables, among others. The system will validate
the information automatically as data is entered, and
avoid duplication of variables that are common among
the subjects, thus reducing the time and margin of error
for data entry. All the information will be stored in a
central database where input from the Dengue Epide-
miological Surveillance Platform will later be
incorporated.
Statistical analysis
Initially, a description of the population will be formu-
lated using exploratory graphical analysis, frequencies
for the categorical variables, and central tendency mea-
sures (means and medians, depending on the distribu-
tion) as well as dispersion measurements (standard
deviation and range) for the continuous variables. Addi-
tionally, the incidence of infection will be determined in
the exposed and non-exposed groups and the RR will be
calculated.
Subsequently, with recent DENV infection as the
dependent variable, an appropriate bivariate analysis will
be conducted to assess whether an association exists. Of
course, the specific method of analysis will depend on
properties of the data and validation of assumptions.
But possible methods include the chi-square test (for
the categorical variables) and either Student’s t or the
Mann-Whitney test (for the continuous variables). Vari-
ables presenting p < 0,20 in the bivariate analysis will be
evaluated under a binomial regression analysis or an
alternate model to obtain a multivariate model suscepti-
ble of explaining the DENV-infection incidence; vari-
ables presenting p < 0,05 or altering the principal
variable estimate by 10% or more will remain in the
model.
The model will not include the estimated vector den-
sity variables, since they are part of the causal mechanism
underlying the principal variable association (IC exposure
- new infections). However, once the explanatory model
has been adjusted to the confounding variables and
established, the estimated vector abundance measures
will be incorporated (each one separately), with the view
of identifying to what extent the vector component might
explain the principal variable association. For this pur-
pose, two variables will be considered: mosquito abun-
dance estimated indirectly through ovitraps, and vector
density estimated directly by measuring the larvae in the
homes of the participating subjects. The analysis will be
performed with the Stata SE 10 statistics package, includ-
ing any necessary diagnostic checks.
Ethical considerations
The present study is a minimal-risk research project
approved by the Ethics Commission of the National
Institute of Public Health (CI: 986, No.1032). Each sub-
ject will be requested a written informed consent for
her/his participation in the study. If the subject is a
minor (from five to 17 years of age), authorization will
be sought from a parent or legal representative. How-
ever, if the subject is seven or older, her/his assent will
be requested as well.
Discussion
The development of optimal and successful programs
for dengue surveillance and control requires an under-
standing of where subjects are infected. The scientific
evidence derived from this study will make it possible to
discern whether dengue transmission occurs in or out-
side the peridomestic areas of infected cases. Results
indicating a high infection rate among the subjects
exposed to symptomatic dengue cases would support
implementing vector-control measures in the domiciles
and vicinities of the cases, and would suggest the need
to evaluate alternate causes for insufficient program
impact, causes such as inadequate space nebulization
techniques and vector resistance to applied insecticides.
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However, results indicating that subjects are infected
in the peridomestic areas of symptomatic dengue cases
at a frequency that is equal or inferior to that of subjects
infected in areas not exposed to symptomatic cases,
would support the hypothesis that infection occurs out-
side the domiciles, and would explain why the anti-vec-
tor measures applied in the state of Morelos have
proved ineffective. These findings would be used both
to reassessing and redirecting the selection of sites for
prevention and control interventions, also to designing a
new proposal for vector-control programs.
An alternate explanation for non-association between
IC exposure and new dengue infections may reside in
the fact that the “non-exposed” groups could have actu-
ally been exposed, but to cases undetected by the epide-
miological surveillance system. This finding would call
into question the strategy followed by the epidemiologi-
cal surveillance system to detect and notify cases, which,
in themselves, constitute the basis for targeting the com-
munity prevention and control interventions implemen-
ted by the health authorities.
One of the strengths of the present study refers to its
exhaustive (IgM and IgG) diagnostic algorithm which,
based on paired samples to confirm recent DENV infec-
tion, facilitates an adequate classification of the disease
-both symptomatic and asymptomatic- among study
subjects. This is highly relevant considering that the
immune status of the population is as yet unknown, and
could account for different immunological response pat-
terns (relating to primary and secondary infection).
A further strength resides in the prospective detection
of asymptomatic-infection subjects, considering that few
studies have centered their observation on cases with no
clinical manifestations, the case-environment interaction
or the participation of cases in the transmission chain.
This information is fundamental for assessing the
impact that will be achieved by the DENV vaccines cur-
rently being piloted in several Latin American countries,
including Mexico. It will also serve to assess the mini-
mum coverage required to obtain a herd-immunity
effect on the population.
As it is impossible to monitor and ascertain vector
density in the domiciles of the participating subjects
prior to and during follow up, it will be estimated
according to the data from the ovitrap-based SSM sur-
veillance program (a permanent but indirect measure-
ment). Additionally, vector index inspections will be
performed during visits to the subjects’ dwellings (a
direct but single time measurement). Due to the diffi-
cult logistics involved in the capture of adult Aedes,
mosquito infection will be analyzed in the individuals
that emerge from the eggs collected through the ovi-
traps closest to the subjects’ dwellings and from the
larvae/pupae collected at the dwellings themselves.
The two aforementioned limitations may bias the
information obtained on the vector-density and vec-
tor-infection variables. And the reduced measuring
precision may hamper the capacity to evaluate the
relevance of these variables as explanatory compo-
nents of the principal association (IC and infection
incidence).
Another limitation refers to the subject-mobility-mea-
surement procedure. Performed by way of a question-
naire (subjective and retrospective), it entails a potential
memory bias. Nonetheless, as the measurement strategy
for this variable will not be applied differentially among
the groups, in the event of a bias, the association mea-
sure would tend to be null.
Additionally, the applicability of the study results may
be altered by the scarcely predictable epidemiological
behavior of dengue (whether endemic or epidemic),
depending on the moment sampling kicks off. Accord-
ingly, data collection will commence during the second
quarter of the year - a period considered endemic based
on the observations of previous years (Figure 2)–such
that the findings of the project may prove applicable
both in endemic-transmission periods and at the begin-
ning of outbreaks.
Lastly, it has been established that dengue incidence is
directly proportional to the emergence of acute cases
and related deaths. Hence, knowing where the transmis-
sion chain commences would make it possible to focus
the most successful control actions in such a manner
that they exert an impact on halting transmission,
thereby effectively quelling the dengue attack and mor-
tality rates. In this regard, the present study will contri-
bute valuable information towards clarifying whether the
peridomestic areas are in fact the starting point of trans-
mission. Should the contrary be revealed, research
should be redirected to studies which explore sites other
than the subjects’ dwellings for the occurrence of
infection.
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